daklinza

Frequently asked questions

What does Daklinza treat?

Daklinza (Daclatasvir Dihydrochloride) may be used to treat chronic hepatitis c, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

How is Daklinza rated?

pharmaranks gives Daklinza a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.

Is there a coupon or discount for Daklinza?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Daklinza. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Daklinza?

Daklinza is marketed by Bristol Myers Squibb. You can see Bristol Myers Squibb's full profile, rating, and other products on pharmaranks.

Is Daklinza a brand-name or generic drug?

Daklinza is a brand-name product with the active ingredient Daclatasvir Dihydrochloride.

Is Daklinza available over the counter?

No. Daklinza is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Daklinza come in?

Daklinza is currently marketed as tablet, per the FDA's National Drug Code Directory.

Is Daklinza FDA-registered?

Daklinza is on record with the U.S. FDA under application number NDA206843. You can verify this on its official FDA label.

Has Daklinza been recalled by the FDA?

Daklinza has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.

Is Daklinza safe?

There's no single safe-or-not verdict. pharmaranks gives Daklinza a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.